Akero Therapeutics, Inc. 8-K SEC Filings

Filed On	Filing
09 Dec 2025	8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more
03 Dec 2025	8-K: Submission of Matters to a Vote of Security Holders; Other Events
09 Oct 2025	8-K: Entry into a Material Definitive Agreement; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
29 Sep 2025	8-K: Termination of a Material Definitive Agreement
08 Aug 2025	8-K: Results of Operations and Financial Condition
04 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
12 May 2025	8-K: Results of Operations and Financial Condition
28 Feb 2025	8-K: Results of Operations and Financial Condition
30 Jan 2025	8-K: Entry into a Material Definitive Agreement
27 Jan 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure +1 more
08 Nov 2024	8-K: Results of Operations and Financial Condition
09 Aug 2024	8-K: Results of Operations and Financial Condition
12 Jun 2024	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
10 May 2024	8-K: Results of Operations and Financial Condition
18 Mar 2024	8-K: Unregistered Sales of Equity Securities
06 Mar 2024	8-K: Entry into a Material Definitive Agreement
04 Mar 2024	8-K: Regulation FD Disclosure; Other Events
29 Feb 2024	8-K: Results of Operations and Financial Condition
18 Dec 2023	8-K: Regulation FD Disclosure; Other Events
13 Nov 2023	8-K: Results of Operations and Financial Condition

Comments